Novo Nordisk
NVO
#21
Rank
โ‚น38.646 T
Marketcap
โ‚น8,892
Share price
2.57%
Change (1 day)
3.02%
Change (1 year)

Novo Nordisk A / S produces and markets pharmaceutical products and services. Since its founding in Denmark in 1923, the company has developed into a leading company in the diabetes sector worldwide.

Novo Nordisk (NVO) Fails to deliver data

Key failure to deliver metrics for Novo Nordisk:

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Novo Nordisk (NVO) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Novo Nordisk (NVO) - since 2013

Volume in USD (price x number of shares), data since 2013

Novo Nordisk (NVO) Failure to deliver volume, Year over Year

Year Volume (Price x Shares) Change
2024โ‚น0.13 B53.43%
2023โ‚น88.71 M-11.66%
2022โ‚น0.10 B125.23%
2021โ‚น44.58 M70.14%
2020โ‚น26.2 M-57.24%
2019โ‚น61.28 M-22.47%
2018โ‚น79.04 M3.14%
2017โ‚น76.63 M5.66%
2016โ‚น72.53 M-28.24%
2015โ‚น0.10 B-51.63%
2014โ‚น0.20 B598.64%
2013โ‚น29.9 M

FTD volume in the last 3 months for similar companies or competitors

Company FTD volume (3 months) FTD volume (1 year) Country
โ‚น50.21 Mโ‚น0.38 B๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น41.73 Mโ‚น0.14 B๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น29.95 Mโ‚น0.31 B๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น11.64 Mโ‚น71.88 M๐Ÿ‡ซ๐Ÿ‡ท France